Lineweaver Wealth Advisors, LLC Aquestive Therapeutics, Inc. Transaction History
Lineweaver Wealth Advisors, LLC
- $631 Million
- Q4 2025
A detailed history of Lineweaver Wealth Advisors, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Lineweaver Wealth Advisors, LLC holds 10,000 shares of AQST stock, worth $53,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$53,900% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
167Shares Held
66MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...